209 related articles for article (PubMed ID: 14565812)
1. Venlafaxine hydrochloride for the treatment of hot flashes.
Schober CE; Ansani NT
Ann Pharmacother; 2003 Nov; 37(11):1703-7. PubMed ID: 14565812
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin-reuptake inhibitors for the treatment of hot flashes.
De Sloover Koch Y; Ernst ME
Ann Pharmacother; 2004; 38(7-8):1293-6. PubMed ID: 15187211
[TBL] [Abstract][Full Text] [Related]
3. Medroxyprogesterone acetate better than venlafaxine at relieving hot flashes.
J Support Oncol; 2005; 3(4):312. PubMed ID: 16092603
[No Abstract] [Full Text] [Related]
4. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
Loprinzi CL; Levitt R; Barton D; Sloan JA; Dakhil SR; Nikcevich DA; Bearden JD; Mailliard JA; Tschetter LK; Fitch TR; Kugler JW
J Clin Oncol; 2006 Mar; 24(9):1409-14. PubMed ID: 16505409
[TBL] [Abstract][Full Text] [Related]
5. Venlafaxine for hot flushes.
Barlow DH
Lancet; 2000 Dec; 356(9247):2025-6. PubMed ID: 11145483
[No Abstract] [Full Text] [Related]
6. Breast cancer and hot flashes. Options for relief.
Mayo Clin Health Lett; 2001 Mar; 19(3):6. PubMed ID: 11242843
[No Abstract] [Full Text] [Related]
7. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
Carpenter JS; Storniolo AM; Johns S; Monahan PO; Azzouz F; Elam JL; Johnson CS; Shelton RC
Oncologist; 2007 Jan; 12(1):124-35. PubMed ID: 17227907
[TBL] [Abstract][Full Text] [Related]
8. Nonhormonal agents show promise against hot flashes.
Gottlieb N
J Natl Cancer Inst; 2000 Jul; 92(14):1118-20. PubMed ID: 10904081
[No Abstract] [Full Text] [Related]
9. Beyond estrogen: new alternatives for the management of hot flashes.
Dvorak SR
S D J Med; 2002 Jan; 55(1):11-2. PubMed ID: 11808405
[No Abstract] [Full Text] [Related]
10. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.
Joffe H; Guthrie KA; LaCroix AZ; Reed SD; Ensrud KE; Manson JE; Newton KM; Freeman EW; Anderson GL; Larson JC; Hunt J; Shifren J; Rexrode KM; Caan B; Sternfeld B; Carpenter JS; Cohen L
JAMA Intern Med; 2014 Jul; 174(7):1058-66. PubMed ID: 24861828
[TBL] [Abstract][Full Text] [Related]
11. Treatment for hot flushes in women receiving tamoxifen.
Bydder SA; Spry NA
Med J Aust; 2002 Sep; 177(5):266. PubMed ID: 12197825
[No Abstract] [Full Text] [Related]
12. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
[TBL] [Abstract][Full Text] [Related]
13. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
Loibl S; Schwedler K; von Minckwitz G; Strohmeier R; Mehta KM; Kaufmann M
Ann Oncol; 2007 Apr; 18(4):689-93. PubMed ID: 17229772
[TBL] [Abstract][Full Text] [Related]
14. Nonhormonal alternatives for the treatment of hot flashes.
Sicat BL; Brokaw DK
Pharmacotherapy; 2004 Jan; 24(1):79-93. PubMed ID: 14740790
[TBL] [Abstract][Full Text] [Related]
15. Concern about the use of venlafaxine to treat vasomotor symptoms.
Zhou SS; Lun YZ; Li D
JAMA Intern Med; 2015 Apr; 175(4):657-8. PubMed ID: 25844750
[No Abstract] [Full Text] [Related]
16. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.
Loprinzi CL; Pisansky TM; Fonseca R; Sloan JA; Zahasky KM; Quella SK; Novotny PJ; Rummans TA; Dumesic DA; Perez EA
J Clin Oncol; 1998 Jul; 16(7):2377-81. PubMed ID: 9667254
[TBL] [Abstract][Full Text] [Related]
17. Concern about the use of venlafaxine to treat vasomotor symptoms--reply.
Joffe H; LaCroix AZ; Cohen L
JAMA Intern Med; 2015 Apr; 175(4):658-9. PubMed ID: 25844753
[No Abstract] [Full Text] [Related]
18. Venlafaxine for the control of hot flashes: results of a longitudinal continuation study.
Barton D; La Vasseur B; Loprinzi C; Novotny P; Wilwerding MB; Sloan J
Oncol Nurs Forum; 2002; 29(1):33-40. PubMed ID: 11817491
[TBL] [Abstract][Full Text] [Related]
19. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.
Loprinzi CL; Flynn PJ; Carpenter LA; Atherton P; Barton DL; Shanafelt TD; Rummans TA; Sloan JA; Adjei AA; Mincey BA; Fitch TR; Collins M
J Palliat Med; 2005 Oct; 8(5):924-30. PubMed ID: 16238505
[TBL] [Abstract][Full Text] [Related]
20. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
Boekhout AH; Vincent AD; Dalesio OB; van den Bosch J; Foekema-Töns JH; Adriaansz S; Sprangers S; Nuijen B; Beijnen JH; Schellens JH
J Clin Oncol; 2011 Oct; 29(29):3862-8. PubMed ID: 21911720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
